CYBN Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 16:00):

Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a phenethylamine derivative to treat neuroinflammation...

Stats
Today's Volume	2.13M
Average Volume	5.39M
Market Cap	255.92M
EPS	$0 ( 2024-02-13 )
Next earnings date	( $-0.0300 ) 2024-06-25
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.590
ATR14	$0.00100 (0.29%)

Volume Correlation

Long: 0.05 (neutral)

Short: -0.89 (strong negative)

Signal:(43.368) Neutral

Cybin Inc. Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Cybin Inc. Correlation - Currency/Commodity

0.00
( neutral )

-0.33
( neutral )

Cybin Inc. Financials

Annual	2022
Revenue:	$0
Gross Profit:	$-251 000 (0.00 %)
EPS:	$-0.220

FY	2022
Revenue:	$0
Gross Profit:	$-251 000 (0.00 %)
EPS:	$-0.220

FY	2022
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$-0.430

FY	2021
Revenue:	$864 000
Gross Profit:	$200 000 (23.15 %)
EPS:	$-0.320

Financial Reports:

No articles found.

Cybin Inc.